ENTITY
China Regenerative Medicine International

China Regenerative Medicine International (8158 HK)

4
Analysis
Health Care • Hong Kong
China Regenerative Medicine International is a high-end new-technology enterprise focused on the research, development, production, and sales of tissue engineering and regenerative medicine products. Its business encompasses tissue engineering, cosmetics, cell storage and therapy, and hospital administration, with key products including ActivSkin and Acornea. The company was incorporated on April 20, 2001, and is headquartered in Hong Kong.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x